<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Grady KL</submitter><funding>NHLBI NIH HHS</funding><pagination>345-355</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12626348</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Few study authors examined factors influencing health-related quality of life (HRQOL) early after left ventricular assist device (LVAD) implantation.&lt;h4>Objective&lt;/h4>The purpose of this study was to determine whether 5 novel self-report measures and other variables were significantly associated with overall HRQOL at 3 months after LVAD surgery.&lt;h4>Methods&lt;/h4>Patients were recruited between October 26, 2016, and February 29, 2020, from 12 US sites. Data were collected before LVAD implantation and at 3 months post LVAD implantation. Overall HRQOL measures included the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) overall summary score (OSS) and EuroQol 5-dimension- 3L visual analog scale. Potential factors associated with overall HRQOL included 5 novel self-report measures (Satisfaction with Treatment, Being Bothered by VAD Self-care and Limitations, VAD Team Communication, Self-efficacy regarding VAD Self-care, and Stigma), and demographic and clinical characteristics. Statistics included regression analyses.&lt;h4>Results&lt;/h4>Of enrollees, 242 completed self-report measures at baseline, and 142 completed measures 3 months postoperatively. Patients were 55 ± 13 years old, with 21% female, 24% non-White, 39% high school or lower educated, and 47% destination therapy. Using the KCCQ-12 OSS, higher Satisfaction with Treatment was associated with a higher KCCQ-12 OSS; Being Bothered by VAD Self-care and Limitations, high school or lower education, chest incision pain, cardiac dysrhythmias within 3 postoperative months, and peripheral edema were associated with a worse KCCQ-12 OSS ( R2 = 0.524). Factors associated with a worse 3-month EuroQol 5-dimension-3L visual analog scale were female sex, adverse events within 3 months post implantation (cardiac dysrhythmias, bleeding, and venous thrombosis), and chest incision pain ( R2 = 0.229). No factors were associated with a higher EuroQol 5-dimension-3L visual analog scale score at 3 months.&lt;h4>Conclusions&lt;/h4>Two novel measures, demographics, postimplantation adverse events, and symptoms were associated with post-LVAD KCCQ-12 OSS early after surgery.</pubmed_abstract><journal>The Journal of cardiovascular nursing</journal><pubmed_title>Association of Novel Ventricular Assist Device Self-report Measures With Overall Health-Related Quality of Life.</pubmed_title><pmcid>PMC12626348</pmcid><funding_grant_id>R01 HL130502</funding_grant_id><pubmed_authors>Adler E</pubmed_authors><pubmed_authors>Beiser DG</pubmed_authors><pubmed_authors>Rich J</pubmed_authors><pubmed_authors>Denfeld QE</pubmed_authors><pubmed_authors>Lee CS</pubmed_authors><pubmed_authors>Klein L</pubmed_authors><pubmed_authors>Murks C</pubmed_authors><pubmed_authors>Bedjeti K</pubmed_authors><pubmed_authors>Grady KL</pubmed_authors><pubmed_authors>Burns JL</pubmed_authors><pubmed_authors>McIlvennan CK</pubmed_authors><pubmed_authors>Hahn EA</pubmed_authors><pubmed_authors>Allen LA</pubmed_authors><pubmed_authors>Yancy C</pubmed_authors><pubmed_authors>Ruo B</pubmed_authors><pubmed_authors>Lindenfeld J</pubmed_authors><pubmed_authors>Walsh MN</pubmed_authors><pubmed_authors>Stehlik J</pubmed_authors><pubmed_authors>Kirklin JK</pubmed_authors><pubmed_authors>Kiernan M</pubmed_authors><pubmed_authors>Cella D</pubmed_authors><pubmed_authors>Teuteberg J</pubmed_authors><pubmed_authors>Pham DT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Novel Ventricular Assist Device Self-report Measures With Overall Health-Related Quality of Life.</name><description>&lt;h4>Background&lt;/h4>Few study authors examined factors influencing health-related quality of life (HRQOL) early after left ventricular assist device (LVAD) implantation.&lt;h4>Objective&lt;/h4>The purpose of this study was to determine whether 5 novel self-report measures and other variables were significantly associated with overall HRQOL at 3 months after LVAD surgery.&lt;h4>Methods&lt;/h4>Patients were recruited between October 26, 2016, and February 29, 2020, from 12 US sites. Data were collected before LVAD implantation and at 3 months post LVAD implantation. Overall HRQOL measures included the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) overall summary score (OSS) and EuroQol 5-dimension- 3L visual analog scale. Potential factors associated with overall HRQOL included 5 novel self-report measures (Satisfaction with Treatment, Being Bothered by VAD Self-care and Limitations, VAD Team Communication, Self-efficacy regarding VAD Self-care, and Stigma), and demographic and clinical characteristics. Statistics included regression analyses.&lt;h4>Results&lt;/h4>Of enrollees, 242 completed self-report measures at baseline, and 142 completed measures 3 months postoperatively. Patients were 55 ± 13 years old, with 21% female, 24% non-White, 39% high school or lower educated, and 47% destination therapy. Using the KCCQ-12 OSS, higher Satisfaction with Treatment was associated with a higher KCCQ-12 OSS; Being Bothered by VAD Self-care and Limitations, high school or lower education, chest incision pain, cardiac dysrhythmias within 3 postoperative months, and peripheral edema were associated with a worse KCCQ-12 OSS ( R2 = 0.524). Factors associated with a worse 3-month EuroQol 5-dimension-3L visual analog scale were female sex, adverse events within 3 months post implantation (cardiac dysrhythmias, bleeding, and venous thrombosis), and chest incision pain ( R2 = 0.229). No factors were associated with a higher EuroQol 5-dimension-3L visual analog scale score at 3 months.&lt;h4>Conclusions&lt;/h4>Two novel measures, demographics, postimplantation adverse events, and symptoms were associated with post-LVAD KCCQ-12 OSS early after surgery.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul-Aug 01</publication><modification>2026-06-05T19:09:50.109Z</modification><creation>2026-05-20T03:14:14.037Z</creation></dates><accession>S-EPMC12626348</accession><cross_references><pubmed>39259580</pubmed><doi>10.1097/JCN.0000000000001129</doi><doi>10.1097/jcn.0000000000001129</doi></cross_references></HashMap>